Divalproex Sodium
NDC 68071-3553, Divalproex Sodium, tablet, delayed release, from NuCare Pharmaceuticals,Inc..
- Product NDC
- 68071-3553
- Status
- Listed
- Labeler
- NuCare Pharmaceuticals,Inc.
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078597
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68071-3553 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIVALPROEX SODIUM250 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68071-3553-6 | 68071355306 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (68071-3553-6) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/0bef10ed-e4b5-95ae-e063-6294a90a86eb
Use it
Look up 68071-3553 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68071-3553 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68071-3553. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.